BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  BIO-TECHNE ISSUES 2022 CORPORATE SUSTAINABILITY REPORT

  Bio-Techne Corporation (NASDAQ: TECH) today issued its 2022 Corporate Sustainability Report (CSR).

  September 19, 2022

   · 

  2 min read
• Drug Development

  HistoSonics Announces Published Results of Phase I Liver Tumor Trial

  HistoSonics announced today the publication of results from their prospective Phase I clinical trial, named the THERESA Trial, conducted in Barcelona, Spain.

  September 19, 2022

   · 

  3 min read
• CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy

  CollPlant today announced the Company will make a presentation on “Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications” at the International Conference on Biofabrication on September 28th.

  September 19, 2022

   · 

  1 min read
• Numinus Now Offers Ketamine-Assisted Therapy in Toronto

  Numinus Wellness Inc. today announced that its Toronto clinic, the Neurology Centre of Toronto (NCT) by Numinus, is now offering ketamine-assisted therapy for patients with neurologic conditions.

  September 19, 2022

   · 

  6 min read
• Lone Star Bio

  OncoNano Medicine to Present at Cantor Fitzgerald Oncology & HemOnc Conference

  OncoNano Medicine, Inc. today announced that Chief Medical Officer Kartik Krishnan, MD, PhD, will present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference at the Lotte New York Palace in New York City on Wednesday, September 28, 2022.

  September 19, 2022

   · 

  1 min read
• Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia

  Virios Therapeutics, Inc. today announced topline results from its FORTRESS (Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of Herpes Simplex Virus-1 (“HSV-1”)) study of oral IMC-1 for the treatment of FM.

  September 19, 2022

   · 

  7 min read
• Genetown

  BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

  BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma.

  September 19, 2022

   · 

  10 min read
• Business

  Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies

  Gamida Cell Ltd. today announced that Abigail “Abbey” L. Jenkins, MS, has joined as President & CEO.

  September 19, 2022

   · 

  8 min read
• Business

  Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

  Aclarion, Inc. announced today their participation in the Biomarkers for Evaluating Spine Treatments (BEST) Trial funded through the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM.

  September 19, 2022

   · 

  6 min read
• Lone Star Bio

  Instil Bio to Present at Jefferies Cell and Genetic Medicine Summit

  Instil Bio, Inc. today announced that company management will participate in an upcoming investor conference.

  September 19, 2022

   · 

  1 min read